Uploaded August 2026 | Updated September 2026, 2 weeks ago
A Boston-developed pill has won FDA approval for pancreatic cancer, offering new hope after a trial showed patients lived longer.
A Boston-developed pill has won FDA approval for pancreatic cancer, offering new hope after a trial showed patients lived longer.










